this post was submitted on 07 Jul 2023
429 points (98.9% liked)

World News

38978 readers
2843 users here now

A community for discussing events around the World

Rules:

Similarly, if you see posts along these lines, do not engage. Report them, block them, and live a happier life than they do. We see too many slapfights that boil down to "Mom! He's bugging me!" and "I'm not touching you!" Going forward, slapfights will result in removed comments and temp bans to cool off.

We ask that the users report any comment or post that violate the rules, to use critical thinking when reading, posting or commenting. Users that post off-topic spam, advocate violence, have multiple comments or posts removed, weaponize reports or violate the code of conduct will be banned.

All posts and comments will be reviewed on a case-by-case basis. This means that some content that violates the rules may be allowed, while other content that does not violate the rules may be removed. The moderators retain the right to remove any content and ban users.


Lemmy World Partners

News [email protected]

Politics [email protected]

World Politics [email protected]


Recommendations

For Firefox users, there is media bias / propaganda / fact check plugin.

https://addons.mozilla.org/en-US/firefox/addon/media-bias-fact-check/

founded 1 year ago
MODERATORS
 

Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.

you are viewing a single comment's thread
view the rest of the comments
[–] Drewsteau 9 points 1 year ago* (last edited 1 year ago)

Unfortunately the article states a yearly treatment cost would be about $90K with all expenses factored in. Patients with Medicare will likely not be able to get coverage for this, and Medicaid will still require a copay of 20%.

Like every other industry, pharmaceutical companies are profit driven and will maximize their revenue whenever possible, especially when they know the patient population is desperate.

A big example of this was when Pfizer discontinued their research program to cure heart disease, since it is more profitable to charge patients for statins for the rest of their life than it is to cure them.